Immatics (IMTX) Intangibles (2019 - 2025)
Immatics recorded quarterly Intangibles of $1.8 million in Q4 2025, up 0.91% quarter-over-quarter from $1.8 million in Q3 2025, and up 5.79% year-over-year from $1.7 million in Q4 2024.
Immatics' Intangibles history runs 7 years deep, the most recent figure standing at $1.8 million for Q4 2025.
- In Q4 2025, Intangibles rose 5.79% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (up 5.79% YoY), while the FY2025 annual figure was $1.8 million, up 2.68% from the prior year.
- Intangibles came in at $1.8 million for Q4 2025 at Immatics, up from $1.8 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $1.8 million in Q4 2025 to a low of -$676766.2 in Q4 2023.
- A 5-year average of $1.5 million and a median of $1.7 million in 2022 frame the typical range for Intangibles.
- Across the five-year window, Intangibles slumped 140.65% in 2023 and surged 357.21% in 2024, its largest moves.
- Immatics' Intangibles stood at $1.5 million in 2021, then advanced by 10.68% to $1.7 million in 2022, then plunged by 140.65% to -$676766.2 in 2023, then soared by 357.21% to $1.7 million in 2024, then gained by 5.79% to $1.8 million in 2025.
- According to Business Quant data, Intangibles over the past three periods registered $1.8 million, $1.8 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | -676,766.20 |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 1.52 Mn |
| Mar 31, 2021 | 1.11 Mn |
| Dec 31, 2020 | 1.09 Mn |
| Sep 30, 2020 | 1.13 Mn |
| Jun 30, 2020 | 1.09 Mn |
| Dec 31, 2019 | 1.12 Mn |